Sara Westrøm

Title: **Innovator Spotlight: Sara Westrøm**

Introduction

Sara Westrøm is a pioneering inventor based in Oslo, Norway. She has made significant contributions to the field of radiotherapy through her innovative work in developing pharmaceutical compositions designed for cancer treatment. Her expertise and dedication have propelled her to the forefront of medical technology.

Latest Patents

Westrøm holds a notable patent centered on her invention of radiotherapeutic particles and suspensions. The patent describes a pharmaceutical composition that includes one or more particles, or a suspension of differing particles, featuring a degradable compound alongside an alpha-emitting radionuclide and/or a radionuclide generating alpha-emitting daughters. This innovative formulation has the potential to enhance cancer treatment efficacy.

Career Highlights

Currently, Sara Westrøm is associated with Oncoinvent AS, where she focuses on research and development aimed at advancing cancer therapy solutions. Her work not only underscores her commitment to improving patient outcomes but also showcases her expertise in targeting complex challenges within the medical field.

Collaborations

Throughout her career, Westrøm has collaborated with various professionals, including Roy Hartvig Larsen, a fellow innovator in the field. Their partnerships have fostered new ideas and innovations that contribute to the ongoing evolution of cancer treatment technologies.

Conclusion

Sara Westrøm's contributions to the field of medical technology, particularly in cancer treatment, highlight the impact of dedicated inventors on healthcare advancements. With her groundbreaking patent and collaborative spirit, she continues to pave the way for future innovations in the industry.